NDC 62756-233 – Amphotericin B
Amphotericin B 50 mg/1 · Injectable, Liposomal · Intravenous
Product NDC62756-233
Product details
- Brand name
- Amphotericin B
- Generic name
- Amphotericin B
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- Injectable, Liposomal
- Route
- Intravenous
- Marketing category
- ANDA · ANDA212514
- Marketed since
- February 9, 2022
- Listing expires
- December 31, 2027
- Pharmacologic class
- Lipid-based Polyene Antifungal; Polyene Antifungal
Active ingredients
- Amphotericin B 50 mg/1
Uses, dosage, side effects and warnings for Amphotericin B →
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 62756-233-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (62756-233-01) / 1 INJECTABLE, LIPOSOMAL in 1 VIAL, SINGLE-DOSE | Feb 9, 2022 |
| 62756-233-02 | 10 CARTON in 1 CARTON (62756-233-02) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 1 INJECTABLE, LIPOSOMAL in 1 VIAL, SINGLE-DOSE | Feb 9, 2022 |
Recalls mentioning this NDC
- D-0493-2024 May 15, 2024 · Class II
Out of specification for assay
Other Amphotericin B products
- 23155-594 Amphotericin B 50 mg/1 · Injectable, Liposomal · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- 62756-954 Amphotericin B 50 mg/1 · Injectable, Liposomal · Sun Pharmaceutical Industries, Inc.
- 55150-365 Amphotericin B 50 mg/12.5mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 39822-1055 Amphotericin B 50 mg/10mL · Injection, Powder, Lyophilized, For Solution · XGen Pharmaceuticals DJB, Inc.